Skip to main content
. 2017 Jan 17;8(23):37845–37854. doi: 10.18632/oncotarget.14708

Figure 2. Distribution of Patients Developing Local/System Recurrence According to the ypT Stage and M-TTRG Classifications.

Figure 2